BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 11407100)

  • 1. Transient hyperthyroidism in a patient with rheumatoid arthritis treated by etanercept.
    Allanore Y; Brémont C; Kahan A; Menkès CJ
    Clin Exp Rheumatol; 2001; 19(3):356-7. PubMed ID: 11407100
    [No Abstract]   [Full Text] [Related]  

  • 2. Pulmonary rheumatoid nodules in an etanercept-treated patient.
    Hübscher O; Re R; Iotti R
    Arthritis Rheum; 2003 Jul; 48(7):2077-8. PubMed ID: 12847707
    [No Abstract]   [Full Text] [Related]  

  • 3. Silent thyroiditis associated with etanercept in rheumatoid arthritis.
    Andrés E; Limbach FX; Goichot B; Sibilia J
    Ann Rheum Dis; 2002 Jun; 61(6):565. PubMed ID: 12006340
    [No Abstract]   [Full Text] [Related]  

  • 4. Henoch Schönlein purpura following etanercept treatment of rheumatoid arthritis.
    Duffy TN; Genta M; Moll S; Martin PY; Gabay C
    Clin Exp Rheumatol; 2006; 24(2 Suppl 41):S106. PubMed ID: 16859610
    [No Abstract]   [Full Text] [Related]  

  • 5. Listeria monocytogenes septic arthritis in a patient treated with etanercept for rheumatoid arthritis.
    Nadarajah K; Pritchard C
    J Clin Rheumatol; 2005 Apr; 11(2):120-2. PubMed ID: 16357718
    [No Abstract]   [Full Text] [Related]  

  • 6. Organizing pneumonia in a patient with rheumatoid arthritis treated with etanercept.
    Sakaida H; Komase Y; Takemura T
    Mod Rheumatol; 2010 Dec; 20(6):611-6. PubMed ID: 20585825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Etanercept-induced dermatitis in a patient with rheumatoid arthritis.
    Lai-Cheong J; Warren R; Bucknall R; Parslew R
    J Eur Acad Dermatol Venereol; 2006 May; 20(5):614-5. PubMed ID: 16684300
    [No Abstract]   [Full Text] [Related]  

  • 8. Delayed multiple injection site reaction in a rheumatoid arthritis patient treated with etanercept.
    Rajakulendran S; Deighton C
    Rheumatology (Oxford); 2004 Dec; 43(12):1588-9. PubMed ID: 15564639
    [No Abstract]   [Full Text] [Related]  

  • 9. Henoch-Schönlein purpura in a patient with rheumatoid arthritis receiving etanercept.
    Asahina A; Ohshima N; Nakayama H; Shirai A; Juji T; Matsui T
    Eur J Dermatol; 2010; 20(4):521-2. PubMed ID: 20413370
    [No Abstract]   [Full Text] [Related]  

  • 10. Fatal streptococcal toxic shock syndrome in a patient with rheumatoid arthritis treated with etanercept.
    Uthman I; Husari A; Touma Z; Kanj SS
    Rheumatology (Oxford); 2005 Sep; 44(9):1200-1. PubMed ID: 15870144
    [No Abstract]   [Full Text] [Related]  

  • 11. Etanercept-induced Wegener granulomatosis in a patient with rheumatoid arthritis.
    Broshtilova V; Iliev E; Gantcheva M
    Dermatol Ther; 2013; 26(1):73-6. PubMed ID: 23384023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diffuse skin reaction after changing the etanercept formulation.
    Caporali R; Bobbio-Pallavicini F; Caprioli M; Scorletti E; Montecucco C
    Clin Exp Rheumatol; 2008; 26(6):1165. PubMed ID: 19210894
    [No Abstract]   [Full Text] [Related]  

  • 13. Etanercept-induced necrotizing crescentic glomerulonephritis in two patients with rheumatoid arthritis.
    Kaneko K; Nanki T; Hosoya T; Mizoguchi F; Miyasaka N
    Mod Rheumatol; 2010 Dec; 20(6):632-6. PubMed ID: 20617355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is there a link between the use of etanercept and Henoch-Schönlein purpura? Comment on: Henoch-Schonlein purpura in a patient with the rheumatoid arthritis receiving etanercept (Eur J Dermatol 2010; 20: 521-2).
    Park SJ; Kim JH; Shin JI
    Eur J Dermatol; 2011; 21(1):147. PubMed ID: 21227894
    [No Abstract]   [Full Text] [Related]  

  • 15. Interstitial granulomatous dermatitis in a patient with rheumatoid arthritis on etanercept.
    Levine SD; Robinson M; Honda K; Nedorost S
    Cutis; 2009 Jan; 83(1):50. PubMed ID: 19271571
    [No Abstract]   [Full Text] [Related]  

  • 16. Severe pancytopenia following etanercept administration in rheumatoid arthritis.
    Martínez Santana V; Izquierdo Navarro M; Calleja Hernández MÁ; Sánchez Sánchez T; Sainz Gil M
    Int J Rheum Dis; 2012 Aug; 15(4):e78-9. PubMed ID: 22898233
    [No Abstract]   [Full Text] [Related]  

  • 17. Dermatological complications of etanercept therapy for rheumatoid arthritis.
    Misery L; Perrot JL; Gentil-Perret A; Pallot-Prades B; Cambazard F; Alexandre C
    Br J Dermatol; 2002 Feb; 146(2):334-5. PubMed ID: 11903255
    [No Abstract]   [Full Text] [Related]  

  • 18. Demyelinating disease and cutaneous lymphocitic vasculitis after etanercept therapy in a patient with rheumatoid arthritis.
    Clemente RE
    Scand J Rheumatol; 2007; 36(3):244-5; author reply 245. PubMed ID: 17657687
    [No Abstract]   [Full Text] [Related]  

  • 19. [Tuberculosis in two patients after administration of etanercept for rheumatoid arthritis].
    Shimzukawa M; Sakakibara T; Sato M; Okayama H; Miki M; Nakagawa K; Miura M; Ishii T; Sato Y
    Nihon Naika Gakkai Zasshi; 2007 Jul; 96(7):1476-8. PubMed ID: 17682437
    [No Abstract]   [Full Text] [Related]  

  • 20. Ophthalmic manifestations of demyelination secondary to etanercept.
    Do HH; Mohamed A; Klistorner A; Grigg J
    Clin Exp Ophthalmol; 2008 May; 36(4):392-4. PubMed ID: 18700932
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.